$CNFN
CFN Enterprises Inc.

2018 Q2 Form 10-Q Financial Statement

#000143774918015579 Filed on August 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $5.994M
YoY Change -0.15%
Cost Of Revenue $2.365M
YoY Change 16.48%
Gross Profit $3.629M
YoY Change -8.65%
Gross Profit Margin 60.54%
Selling, General & Admin $245.1K $1.752M
YoY Change -86.01% -22.05%
% of Gross Profit 48.27%
Research & Development $987.8K $1.133M
YoY Change -12.85% 16.37%
% of Gross Profit 31.23%
Depreciation & Amortization $11.65K $34.08K
YoY Change -65.8% -64.78%
% of Gross Profit 0.94%
Operating Expenses $245.1K $3.968M
YoY Change -93.82% -3.11%
Operating Profit -$245.1K -$339.6K
YoY Change -27.82% 175.99%
Interest Expense $0.00 -$280.0K
YoY Change -100.0% 33.33%
% of Operating Profit
Other Income/Expense, Net $25.00 -$277.1K
YoY Change -100.01% 31.82%
Pretax Income -$245.1K -$620.0K
YoY Change -60.47% 87.88%
Income Tax
% Of Pretax Income
Net Earnings -$1.564M -$616.7K
YoY Change 153.61% 85.05%
Net Earnings / Revenue -10.29%
Basic Earnings Per Share -$0.02 -$0.01
Diluted Earnings Per Share -$0.02 -$0.01
COMMON SHARES
Basic Shares Outstanding 65.94M 65.28M
Diluted Shares Outstanding 65.94M 65.28M

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.020M $120.0K
YoY Change 750.0% -86.36%
Cash & Equivalents $1.022M $120.4K
Short-Term Investments
Other Short-Term Assets $570.0K $810.0K
YoY Change -29.63% -18.18%
Inventory
Prepaid Expenses
Receivables $2.899M $2.182M
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.489M $3.116M
YoY Change 44.05% -19.2%
LONG-TERM ASSETS
Property, Plant & Equipment $72.83K $3.473M
YoY Change -97.9% 41.94%
Goodwill
YoY Change
Intangibles $4.354M
YoY Change
Long-Term Investments
YoY Change
Other Assets $110.7K $106.2K
YoY Change 4.31% -3.74%
Total Long-Term Assets $4.538M $3.579M
YoY Change 26.8% 39.97%
TOTAL ASSETS
Total Short-Term Assets $4.489M $3.116M
Total Long-Term Assets $4.538M $3.579M
Total Assets $9.027M $6.695M
YoY Change 34.83% 4.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.460M $2.120M
YoY Change 16.04% 13.37%
Accrued Expenses
YoY Change
Deferred Revenue $716.3K
YoY Change
Short-Term Debt $0.00 $380.0K
YoY Change -100.0% -35.59%
Long-Term Debt Due $3.410M $2.480M
YoY Change 37.5%
Total Short-Term Liabilities $6.583M $5.075M
YoY Change 29.73% 106.08%
LONG-TERM LIABILITIES
Long-Term Debt $7.400M $4.490M
YoY Change 64.81% -18.21%
Other Long-Term Liabilities $850.0K $1.275M
YoY Change -33.33%
Total Long-Term Liabilities $850.0K $1.275M
YoY Change -33.33% -76.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.583M $5.075M
Total Long-Term Liabilities $850.0K $1.275M
Total Liabilities $14.84M $10.83M
YoY Change 36.93% 36.33%
SHAREHOLDERS EQUITY
Retained Earnings -$34.36M -$29.79M
YoY Change 15.35% 13.78%
Common Stock $65.94K $65.28K
YoY Change 1.0% 0.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.809M -$4.140M
YoY Change
Total Liabilities & Shareholders Equity $9.027M $6.695M
YoY Change 34.83% 4.39%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$1.564M -$616.7K
YoY Change 153.61% 85.05%
Depreciation, Depletion And Amortization $11.65K $34.08K
YoY Change -65.8% -64.78%
Cash From Operating Activities -$790.0K -$110.0K
YoY Change 618.18% -85.71%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$20.00K
YoY Change 0.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$370.0K -$380.0K
YoY Change -2.63% -30.91%
Cash From Investing Activities -$390.0K -$400.0K
YoY Change -2.5% -28.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.430M 110.0K
YoY Change 1200.0% -90.52%
NET CHANGE
Cash From Operating Activities -790.0K -110.0K
Cash From Investing Activities -390.0K -400.0K
Cash From Financing Activities 1.430M 110.0K
Net Change In Cash 250.0K -400.0K
YoY Change -162.5% 135.29%
FREE CASH FLOW
Cash From Operating Activities -$790.0K -$110.0K
Capital Expenditures -$20.00K -$20.00K
Free Cash Flow -$770.0K -$90.00K
YoY Change 755.56% -88.16%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 aclz Common Stock Issued And Outstanding Percentage Decrease
CommonStockIssuedAndOutstandingPercentageDecrease
0.03
CY2018Q2 aclz Deferred Finance Costs Related Party Noncurrent Net
DeferredFinanceCostsRelatedPartyNoncurrentNet
197103
CY2017Q4 aclz Deferred Finance Costs Related Party Noncurrent Net
DeferredFinanceCostsRelatedPartyNoncurrentNet
0
aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
203486
aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
433404
aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
2038296
aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
aclz Foreign Currency Translation Gain Loss Accumulated Depreciation
ForeignCurrencyTranslationGainLossAccumulatedDepreciation
-3085
CY2018Q2 aclz Other Finance Fees
OtherFinanceFees
12585
CY2017Q2 aclz Other Finance Fees
OtherFinanceFees
24125
aclz Other Finance Fees
OtherFinanceFees
41240
aclz Other Finance Fees
OtherFinanceFees
48250
aclz Payables And Loan Paid By Credit Facility
PayablesAndLoanPaidByCreditFacility
623399
aclz Payables And Loan Paid By Credit Facility
PayablesAndLoanPaidByCreditFacility
aclz Prepaid Expenses Reclassed To Deferred Financing Cost
PrepaidExpensesReclassedToDeferredFinancingCost
70000
aclz Prepaid Expenses Reclassed To Deferred Financing Cost
PrepaidExpensesReclassedToDeferredFinancingCost
aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
25000
aclz Stock Issued During Period Shares Stock Options Exercised Noncash
StockIssuedDuringPeriodSharesStockOptionsExercisedNoncash
1707692
CY2017Q2 aclz Stock Issued During Period Shares Warrants Exercised Noncash
StockIssuedDuringPeriodSharesWarrantsExercisedNoncash
0
aclz Stock Issued During Period Shares Warrants Exercised Noncash
StockIssuedDuringPeriodSharesWarrantsExercisedNoncash
160096
CY2018Q2 aclz Working Capital Deficit
WorkingCapitalDeficit
-2094080
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2455181
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2479083
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2898828
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2692636
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
797778
CY2017Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
55837
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25768596
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16361556
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24423450
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16318872
CY2018Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
181510
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
775152
CY2018Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-55057
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41540
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28543529
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26301748
us-gaap Advertising Cost Policy Expensed Advertising Cost
AdvertisingCostPolicyExpensedAdvertisingCost
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; text-decoration: underline;">Advertising</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The Company expenses advertising costs as incurred.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div> <table style="margin-right: 5%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Three months ended</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Six months ended</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">June 30,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">June 30,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">2018</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">2017</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">2018</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">2017</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Advertising expense</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">142,559</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">83,728</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">276,107</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">170,755</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div></div></div></div></div></div></div></div>
CY2018Q2 us-gaap Advertising Expense
AdvertisingExpense
142559
CY2017Q2 us-gaap Advertising Expense
AdvertisingExpense
83728
us-gaap Advertising Expense
AdvertisingExpense
276107
us-gaap Advertising Expense
AdvertisingExpense
170755
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
66514
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
127564
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
125867
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
251734
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
135343
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
471144
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
384407
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
115644
CY2018Q2 us-gaap Assets
Assets
9027163
CY2017Q4 us-gaap Assets
Assets
7575914
CY2018Q2 us-gaap Assets Current
AssetsCurrent
4489218
CY2017Q4 us-gaap Assets Current
AssetsCurrent
3457862
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1299
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7282
CY2018Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
216146
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
321146
CY2017Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
181531
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
315103
CY2018Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4354377
CY2017Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3925523
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1021833
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166883
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
216883
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1730127
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1071833
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
170422
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
854950
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1559705
CY2018Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65939709
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65939709
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65939709
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65939709
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
65938
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
65938
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1595191
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-601532
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2834020
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-652676
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risks</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The Company&#x2019;s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,000.</div> During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2017, </div>the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div> of the Company&#x2019;s customers accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of its accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.&nbsp;&nbsp;</div>The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require any collateral from its customers.</div></div></div></div></div></div></div></div></div></div>
CY2018Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
716330
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
299937
CY2018Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
716330
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
299937
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
2469136
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
2365364
us-gaap Cost Of Revenue
CostOfRevenue
4822996
us-gaap Cost Of Revenue
CostOfRevenue
3910709
CY2018Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
1440601
CY2017Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
245584
CY2018Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2017Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2018Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
519636
CY2017Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
82868
CY2018Q2 us-gaap Depreciation
Depreciation
11653
CY2017Q2 us-gaap Depreciation
Depreciation
34075
us-gaap Depreciation
Depreciation
25712
us-gaap Depreciation
Depreciation
69530
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
346858
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
384633
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-13517
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19257
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
25833
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y90D
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2833350
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2512203
CY2018Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7187727
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6437726
CY2018Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4354377
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3925523
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-902
CY2016 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-2200000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1906277
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1751672
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3906163
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3677914
CY2018Q2 us-gaap Gross Profit
GrossProfit
2928542
CY2017Q2 us-gaap Gross Profit
GrossProfit
3628790
us-gaap Gross Profit
GrossProfit
6567430
us-gaap Gross Profit
GrossProfit
8040169
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-188443
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-753229
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-129609
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29968
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
416393
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
37767
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-12388
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3582
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
40214
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
365332
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4354377
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3925523
CY2018Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
536850
CY2017Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
278129
us-gaap Interest Expense Debt
InterestExpenseDebt
1139965
us-gaap Interest Expense Debt
InterestExpenseDebt
558581
CY2018Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
338370
CY2017Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
198955
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
711627
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
395545
us-gaap Interest Paid Net
InterestPaidNet
711627
us-gaap Interest Paid Net
InterestPaidNet
395545
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
25
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1042
us-gaap Investment Income Interest
InvestmentIncomeInterest
786
us-gaap Investment Income Interest
InvestmentIncomeInterest
742
CY2018Q2 us-gaap Liabilities
Liabilities
14835940
CY2017Q4 us-gaap Liabilities
Liabilities
12792452
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9027163
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7575914
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6583298
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7059026
CY2018Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3411787
CY2017Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3055812
CY2018Q2 us-gaap Litigation Reserve
LitigationReserve
1275000
CY2018Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
6119381
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4402988
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3538985
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
119163
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-778698
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-923578
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1891820
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-774547
us-gaap Net Income Loss
NetIncomeLoss
-2820503
us-gaap Net Income Loss
NetIncomeLoss
-671933
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
795
CY2018Q2 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
870611
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
844557
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72833
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69405
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1564044
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-616709
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-536825
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-277087
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1139179
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-557839
CY2018Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
352897
CY2017Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
CY2018Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
3955761
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
3968412
us-gaap Operating Expenses
OperatingExpenses
8248754
us-gaap Operating Expenses
OperatingExpenses
8154263
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1027219
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-339622
us-gaap Operating Income Loss
OperatingIncomeLoss
-1681324
us-gaap Operating Income Loss
OperatingIncomeLoss
-114094
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
110735
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123124
CY2018Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-31147
CY2017Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
15177
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-13517
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
19257
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-31147
CY2017Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15177
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13517
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
19257
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
850000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1062500
CY2018Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
930364
CY2017Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
267938
CY2018Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
CY2017Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
1224194
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28698
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32980
CY2018Q2 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
375000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
750000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
891393
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
518557
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
548343
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4702197
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1150000
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-335801
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
17211
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2163212
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1030837
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
987776
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1133437
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2110399
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2176556
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34363187
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31542684
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5397678
CY2017Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5994154
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11390426
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11950878
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1061708
CY2017Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1083303
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2232192
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2299793
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7245000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8302500
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.40
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.40
us-gaap Stock Issued1
StockIssued1
us-gaap Stock Issued1
StockIssued1
1868
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2400000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-5808777
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-5216538
CY2017Q4 us-gaap Subordinated Debt
SubordinatedDebt
625000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</div></div></div></div></div></div></div></div></div></div>
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65939709
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65283042
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65939709
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65272723
CY2018Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65939709
CY2017Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65283042
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65939709
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65272723
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65939709
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65283042
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65939709
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65272723

Files In Submission

Name View Source Status
0001437749-18-015579-index-headers.html Edgar Link pending
0001437749-18-015579-index.html Edgar Link pending
0001437749-18-015579.txt Edgar Link pending
0001437749-18-015579-xbrl.zip Edgar Link pending
aclz-20180630.xml Edgar Link completed
aclz-20180630.xsd Edgar Link pending
aclz-20180630_cal.xml Edgar Link unprocessable
aclz-20180630_def.xml Edgar Link unprocessable
aclz-20180630_lab.xml Edgar Link unprocessable
aclz-20180630_pre.xml Edgar Link unprocessable
aclz20180630_10q.htm Edgar Link pending
ex_119428.htm Edgar Link pending
ex_119429.htm Edgar Link pending
ex_119430.htm Edgar Link pending
ex_119431.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending